Co-Diagnostics, Inc. Sale of Stock, Consideration Received on Transaction
Co-Diagnostics, Inc. (CODX) reported Sale of Stock, Consideration Received on Transaction of $4.90 million for the 1-month period ending 2019-02-28, per its 10-K filed 2021-03-25.
Discontinued › Notes › Equity
us-gaap:SaleOfStockConsiderationReceivedOnTransaction · last filed 2021-03-25
- 2019-02-28: Sale of Stock, Consideration Received on Transaction 1 month $4.90M.
| Period end | Sale of Stock, Consideration Received on Transaction 1 month |
|---|---|
| 2019-02-28 | $4.90M 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |